title: Synthesis, characterization and controlled drug release from temperature-responsive poly(ether-urethane) particles based on PEG-diisocyanates and aliphatic diols.
abstract: A series of linear amphiphilic poly(ether-urethane)s with alternative hydrophilic/hydrophobic segments based on PEG-diisocyanates and aliphatic diols is developed. The molecular structures of the copolymers were confirmed with nuclear magnetic resonance, Fourier transform infrared spectra and gel permeation chromatography. Nanoparticles prepared by self-assembly of the resulting copolymers show sharp temperature-responsive phase transition. The phase transition temperature could be easily modulated by the length of hydrophilic or hydrophobic segments of the polymer. The mechanism of the temperature-responsive behaviour is discussed. In the presence of these obtained poly(ether-urethane)s, doxorubicin (DOX) could be dispersed into aqueous solution. The ratio of DOX release from polymeric particles increased sharply above the phase transition temperature, while the release was suppressed below the phase transition temperature. A controlled drug release can be achieved by changing the environmental temperature. The easy-prepared polymeric nanoparticles, with features of biocompatibility, biodegradability and tail-made temperature responsiveness, are a kind of promising carriers for temperature-controllable drug release.
authors.affiliation: Key Laboratory of Functional Polymer Materials of MOE, Institute of Polymer Chemistry, Nankai University, Tianjin, P.R. China.
authors.forename: Yangyun
authors.initials: Y
authors.lastname: Wang
authors.forename: Guolin
authors.initials: G
authors.lastname: Wu
authors.forename: Xiaomeng
authors.initials: X
authors.lastname: Li
authors.forename: Yinong
authors.initials: Y
authors.lastname: Wang
authors.forename: Hui
authors.initials: H
authors.lastname: Gao
authors.forename: Jianbiao
authors.initials: J
authors.lastname: Ma
mesh_terms: D000818:Animals; D060326:Chemistry Techniques, Synthetic; D003692:Delayed-Action Preparations; D004317:Doxorubicin / Q000737:chemistry; D004337:Drug Carriers / Q000138:chemical synthesis* / Q000737:chemistry* / Q000633:toxicity; D006018:Glycols / Q000737:chemistry*; D017953:Isocyanates / Q000737:chemistry*; D008422:Materials Testing; D051379:Mice; D041681:NIH 3T3 Cells; D053758:Nanoparticles / Q000737:chemistry; D011092:Polyethylene Glycols / Q000737:chemistry*; D011140:Polyurethanes / Q000737:chemistry*; D013696:Temperature
chemical_list: D003692:Delayed-Action Preparations; D004337:Drug Carriers; D006018:Glycols; D017953:Isocyanates; D011140:Polyurethanes; C115016:polyetherurethane; D011092:Polyethylene Glycols; D004317:Doxorubicin